Academic Journal
Children's outcomes in medulloblastoma proton versus photon craniospinal radiotherapy (CURE): meta-analysis.
| Title: | Children's outcomes in medulloblastoma proton versus photon craniospinal radiotherapy (CURE): meta-analysis. |
|---|---|
| Authors: | Viani GA; Hospital das Clínicas of Botucatu Medical School, University of State of São Paulo (UNESP), Botucatu, SP, Brazil; Latin America Cooperative Oncology Group (LACOG), Porto Alegre, Brazil; Master's Program in Applied Health Sciences at the University of Vassouras, Rio de Janeiro, Brazil. Electronic address: gustavo.viani@unesp.br., Hamamura AC; Hospital das Clínicas of Botucatu Medical School, University of State of São Paulo (UNESP), Botucatu, SP, Brazil., Arruda CV; Medical Physics at Radiocare, Oncolcinicas, Brazil., Cardoso CE; Master's Program in Applied Health Sciences at the University of Vassouras, Rio de Janeiro, Brazil., Salmon HA; Director of the Radiotherapy Department at the University of Vassouras. Rio de Janeiro, Brazil., Amaral GO; General Superintendent of FUSVE and Professor in the Business Administration Program at the University of Vassouras, Rio de Janeiro, Brazil. |
| Source: | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2026 Oct; Vol. 223, pp. 111367. Date of Electronic Publication: 2026 Jan 11. |
| Publication Type: | Comparative Study; Journal Article; Meta-Analysis; Systematic Review |
| Language: | English |
| Journal Info: | Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE |
| Imprint Name(s): | Publication: Limerick : Elsevier Scientific Publishers Original Publication: Amsterdam : Elsevier Science Publishers, c1983- |
| MeSH Terms: | Cerebellar Neoplasms*/radiotherapy , Cerebellar Neoplasms*/mortality , Craniospinal Irradiation*/adverse effects , Craniospinal Irradiation*/methods , Medulloblastoma*/radiotherapy , Medulloblastoma*/mortality , Photons*/therapeutic use , Photons*/adverse effects , Proton Therapy*/adverse effects , Proton Therapy*/methods, Child ; Humans ; Treatment Outcome |
| Abstract: | Objective: To compare the efficacy and toxicity of craniospinal irradiation (CSI) with proton (PBT) versus photon (PHT) therapy in pediatric patients with medulloblastoma, evaluating overall survival (OS), growth hormone deficiency (GHD), hypothyroidism, neurocognitive decline, and ototoxicity. Materials and Methods: A systematic review and meta-analysis followed PRISMA and Cochrane guidelines. Retrospective or prospective cohort studies comparing PBT versus PHT-CSI in children (<21 years) with medulloblastoma were included. Outcomes were OS, GHD, hypothyroidism, neurocognitive decline (full-scale IQ), and ototoxicity (grade ≥ 3). Data from 12 studies were extracted and analyzed using a fixed-effects model, calculating risk ratios (RR) for binary outcomes and standardized mean differences (SMD) for continuous outcomes. Heterogeneity was assessed with Cochran's Q test and I2 statistic. Results: Ten cohort studies were included (no randomized trials), including 1034 patients (PBT = 537 and PHT = 497). No difference in OS was observed (RR: 0.984; 95 % CI: 0.902-1.073; p = 0.7118; I2 = 0 %). PBT significantly reduced GHD (RR: 0.379; p < 0.001, NNT = 2), hypothyroidism (RR: 0.256; p < 0.001, NNT = 2), and neurocognitive decline (SMD: 0.708; p = 0.0001, NNT = 5), with no difference in grade ≥ 3 ototoxicity (RR: 0.88; p = 0.5704). Grade ≤ 2 ototoxicity was increased with PHT (RR: 1.15; p = 0.01, NNT = 15). Conclusion: PBT-CSI provides equivalent survival to PHT-CSI while significantly reducing GHD, hypothyroidism, mild ototoxicity, and neurocognitive toxicities in children with medulloblastoma. These findings support the preferential use of PBT to minimize long-term sequelae, though prospective studies are needed to confirm benefits and assess cost-effectiveness. (Copyright © 2026 Elsevier B.V. All rights reserved.) |
| Competing Interests: | Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. |
| Contributed Indexing: | Keywords: Medulloblastoma; Meta-analysis; Proton therapy; Radiotherapy; Survival |
| Entry Date(s): | Date Created: 20260113 Date Completed: 20260924 Latest Revision: 20260925 |
| Update Code: | 20260926 |
| DOI: | 10.1016/j.radonc.2026.111367 |
| PMID: | 41529731 |
| Database: | MEDLINE |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://www.doi.org/10.1016/j.radonc.2026.111367? Name: ScienceDirect (all content) (s7799221) Category: fullText Text: View record from ScienceDirect MouseOverText: View record from ScienceDirect – Url: https://resolver.ebsco.com/c/fiv2js/result?sid=EBSCO:cmedm&genre=article&issn=18790887&ISBN=&volume=223&issue=&date=20261001&spage=111367&pages=111367&title=Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology&atitle=Children%27s%20outcomes%20in%20medulloblastoma%20proton%20versus%20photon%20craniospinal%20radiotherapy%20%28CURE%29%3A%20meta-analysis.&aulast=Viani%20GA&id=DOI:10.1016/j.radonc.2026.111367 Name: Full Text Finder (for New FTF UI) (ns324271) Category: fullText Text: Full Text Finder MouseOverText: Full Text Finder |
|---|---|
| Header | DbId: cmedm DbLabel: MEDLINE An: 41529731 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Children's outcomes in medulloblastoma proton versus photon craniospinal radiotherapy (CURE): meta-analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Viani+GA%22">Viani GA</searchLink>; Hospital das Clínicas of Botucatu Medical School, University of State of São Paulo (UNESP), Botucatu, SP, Brazil; Latin America Cooperative Oncology Group (LACOG), Porto Alegre, Brazil; Master's Program in Applied Health Sciences at the University of Vassouras, Rio de Janeiro, Brazil. Electronic address: gustavo.viani@unesp.br.<br /><searchLink fieldCode="AU" term="%22Hamamura+AC%22">Hamamura AC</searchLink>; Hospital das Clínicas of Botucatu Medical School, University of State of São Paulo (UNESP), Botucatu, SP, Brazil.<br /><searchLink fieldCode="AU" term="%22Arruda+CV%22">Arruda CV</searchLink>; Medical Physics at Radiocare, Oncolcinicas, Brazil.<br /><searchLink fieldCode="AU" term="%22Cardoso+CE%22">Cardoso CE</searchLink>; Master's Program in Applied Health Sciences at the University of Vassouras, Rio de Janeiro, Brazil.<br /><searchLink fieldCode="AU" term="%22Salmon+HA%22">Salmon HA</searchLink>; Director of the Radiotherapy Department at the University of Vassouras. Rio de Janeiro, Brazil.<br /><searchLink fieldCode="AU" term="%22Amaral+GO%22">Amaral GO</searchLink>; General Superintendent of FUSVE and Professor in the Business Administration Program at the University of Vassouras, Rio de Janeiro, Brazil. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228407192%22">Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</searchLink> [Radiother Oncol] 2026 Oct; Vol. 223, pp. 111367. <i>Date of Electronic Publication: </i>2026 Jan 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Comparative Study; Journal Article; Meta-Analysis; Systematic Review – Name: Language Label: Language Group: Lang Data: English – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Scientific+Publishers%22">Elsevier Scientific Publishers </searchLink><i>Country of Publication: </i>Ireland <i>NLM ID: </i>8407192 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0887 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201678140%22">01678140 </searchLink><i>NLM ISO Abbreviation: </i>Radiother Oncol <i>Subsets: </i>MEDLINE – Name: PublisherInfo Label: Imprint Name(s) Group: PubInfo Data: <i>Publication</i>: Limerick : Elsevier Scientific Publishers<br /><i>Original Publication</i>: Amsterdam : Elsevier Science Publishers, c1983- – Name: SubjectMESH Label: MeSH Terms Group: Su Data: <searchLink fieldCode="MM" term="%22Cerebellar+Neoplasms%22">Cerebellar Neoplasms*</searchLink>/<searchLink fieldCode="MM" term="%22Cerebellar+Neoplasms+radiotherapy%22">radiotherapy</searchLink> <br /><searchLink fieldCode="MM" term="%22Cerebellar+Neoplasms%22">Cerebellar Neoplasms*</searchLink>/<searchLink fieldCode="MM" term="%22Cerebellar+Neoplasms+mortality%22">mortality</searchLink> <br /><searchLink fieldCode="MM" term="%22Craniospinal+Irradiation%22">Craniospinal Irradiation*</searchLink>/<searchLink fieldCode="MM" term="%22Craniospinal+Irradiation+adverse+effects%22">adverse effects</searchLink> <br /><searchLink fieldCode="MM" term="%22Craniospinal+Irradiation%22">Craniospinal Irradiation*</searchLink>/<searchLink fieldCode="MM" term="%22Craniospinal+Irradiation+methods%22">methods</searchLink> <br /><searchLink fieldCode="MM" term="%22Medulloblastoma%22">Medulloblastoma*</searchLink>/<searchLink fieldCode="MM" term="%22Medulloblastoma+radiotherapy%22">radiotherapy</searchLink> <br /><searchLink fieldCode="MM" term="%22Medulloblastoma%22">Medulloblastoma*</searchLink>/<searchLink fieldCode="MM" term="%22Medulloblastoma+mortality%22">mortality</searchLink> <br /><searchLink fieldCode="MM" term="%22Photons%22">Photons*</searchLink>/<searchLink fieldCode="MM" term="%22Photons+therapeutic+use%22">therapeutic use</searchLink> <br /><searchLink fieldCode="MM" term="%22Photons%22">Photons*</searchLink>/<searchLink fieldCode="MM" term="%22Photons+adverse+effects%22">adverse effects</searchLink> <br /><searchLink fieldCode="MM" term="%22Proton+Therapy%22">Proton Therapy*</searchLink>/<searchLink fieldCode="MM" term="%22Proton+Therapy+adverse+effects%22">adverse effects</searchLink> <br /><searchLink fieldCode="MM" term="%22Proton+Therapy%22">Proton Therapy*</searchLink>/<searchLink fieldCode="MM" term="%22Proton+Therapy+methods%22">methods</searchLink><br /><searchLink fieldCode="MH" term="%22Child%22">Child</searchLink> ; <searchLink fieldCode="MH" term="%22Humans%22">Humans</searchLink> ; <searchLink fieldCode="MH" term="%22Treatment+Outcome%22">Treatment Outcome</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Objective: To compare the efficacy and toxicity of craniospinal irradiation (CSI) with proton (PBT) versus photon (PHT) therapy in pediatric patients with medulloblastoma, evaluating overall survival (OS), growth hormone deficiency (GHD), hypothyroidism, neurocognitive decline, and ototoxicity.<br />Materials and Methods: A systematic review and meta-analysis followed PRISMA and Cochrane guidelines. Retrospective or prospective cohort studies comparing PBT versus PHT-CSI in children (&lt;21 years) with medulloblastoma were included. Outcomes were OS, GHD, hypothyroidism, neurocognitive decline (full-scale IQ), and ototoxicity (grade ≥ 3). Data from 12 studies were extracted and analyzed using a fixed-effects model, calculating risk ratios (RR) for binary outcomes and standardized mean differences (SMD) for continuous outcomes. Heterogeneity was assessed with Cochran's Q test and I2 statistic.<br />Results: Ten cohort studies were included (no randomized trials), including 1034 patients (PBT = 537 and PHT = 497). No difference in OS was observed (RR: 0.984; 95 % CI: 0.902-1.073; p = 0.7118; I<superscript>2</superscript> = 0 %). PBT significantly reduced GHD (RR: 0.379; p &lt; 0.001, NNT = 2), hypothyroidism (RR: 0.256; p &lt; 0.001, NNT = 2), and neurocognitive decline (SMD: 0.708; p = 0.0001, NNT = 5), with no difference in grade ≥ 3 ototoxicity (RR: 0.88; p = 0.5704). Grade ≤ 2 ototoxicity was increased with PHT (RR: 1.15; p = 0.01, NNT = 15).<br />Conclusion: PBT-CSI provides equivalent survival to PHT-CSI while significantly reducing GHD, hypothyroidism, mild ototoxicity, and neurocognitive toxicities in children with medulloblastoma. These findings support the preferential use of PBT to minimize long-term sequelae, though prospective studies are needed to confirm benefits and assess cost-effectiveness.<br /> (Copyright © 2026 Elsevier B.V. All rights reserved.) – Name: Abstract Label: Competing Interests Group: Ab Data: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. – Name: SubjectMinor Label: Contributed Indexing Group: Data: <i>Keywords: </i>Medulloblastoma; Meta-analysis; Proton therapy; Radiotherapy; Survival – Name: DateEntry Label: Entry Date(s) Group: Date Data: <i>Date Created: </i>20260113 <i>Date Completed: </i>20260924 <i>Latest Revision: </i>20260925 – Name: DateUpdate Label: Update Code Group: Date Data: 20260926 – Name: DOI Label: DOI Group: ID Data: 10.1016/j.radonc.2026.111367 – Name: AN Label: PMID Group: ID Data: 41529731 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cmedm&AN=41529731 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.radonc.2026.111367 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 111367 Subjects: – SubjectFull: Child Type: general – SubjectFull: Humans Type: general – SubjectFull: Treatment Outcome Type: general – SubjectFull: Cerebellar Neoplasms radiotherapy Type: general – SubjectFull: Cerebellar Neoplasms mortality Type: general – SubjectFull: Craniospinal Irradiation adverse effects Type: general – SubjectFull: Craniospinal Irradiation methods Type: general – SubjectFull: Medulloblastoma radiotherapy Type: general – SubjectFull: Medulloblastoma mortality Type: general – SubjectFull: Photons therapeutic use Type: general – SubjectFull: Photons adverse effects Type: general – SubjectFull: Proton Therapy adverse effects Type: general – SubjectFull: Proton Therapy methods Type: general Titles: – TitleFull: Children's outcomes in medulloblastoma proton versus photon craniospinal radiotherapy (CURE): meta-analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Viani GA – PersonEntity: Name: NameFull: Hamamura AC – PersonEntity: Name: NameFull: Arruda CV – PersonEntity: Name: NameFull: Cardoso CE – PersonEntity: Name: NameFull: Salmon HA – PersonEntity: Name: NameFull: Amaral GO IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2026 Oct Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1879-0887 Numbering: – Type: volume Value: 223 Titles: – TitleFull: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Type: main |
| ResultId | 1 |